Trade Desk’s Publicis Clash Sends Shares Tumbling

Trade Desk ( (TTD) ) has fallen by -10.97%. Read on to learn why.

Trade Desk shares fell 10.97% over the past week as investors reacted to mounting worries over its relationship with major advertising agencies, particularly French giant Publicis Groupe. Publicis has stopped recommending Trade Desk’s platform to clients after a third‑party audit alleged unclear fees and media cost reporting, a move that sparked a sharp two‑day slide of more than 10% and intensified concerns about trust and transparency in the company’s ad‑buying tools. The audit findings, which Trade Desk disputes on confidentiality grounds, raised fears that other agencies might follow suit, pressuring a stock already down heavily year‑to‑date.

The turbulence has triggered a flurry of fresh analyst calls and target cuts that helped drive the latest 10.97% weekly drop. Stifel and Rosenblatt both downgraded Trade Desk and slashed their price targets, citing increased uncertainty around growth, a lack of near‑term catalysts, and growing pressure from agency partners. These downgrades came on top of a broader market narrative that the company is facing slower growth and tougher competition in digital advertising, keeping sentiment fragile despite Trade Desk’s continued profitability and recent revenue growth.

Yet the picture is not one‑sided. Several analysts, including at Needham, KeyBanc, RBC Capital, Scotiabank and TipRanks‑OpenAI, argue that the rift with Publicis is more about economics and negotiation leverage than a fundamental threat to Trade Desk’s business model. They highlight that direct deals with big brands now account for most of Trade Desk’s revenue, limiting agencies’ ability to divert spending away from the platform. Wall Street’s overall view remains a Moderate Buy, with an average target price implying sizeable upside if the Publicis dispute is resolved and client spending remains resilient—setting up the recent 10.97% slide as a potential opportunity for investors willing to stomach near‑term volatility.